NCT00285883View on ClinicalTrials.gov

Directly Observed Therapy in High Risk Populations in Newark, NJ

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

May 31, 2006

Conditions
Directly Observed TherapyHIV Infections
Interventions
DRUG

Invirase

DRUG

Norvir

Trial Locations (1)

07102

Saint Michael's Medical Center, Newark

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Saint Michael's Medical Center

OTHER

NCT00285883 - Directly Observed Therapy in High Risk Populations in Newark, NJ | Biotech Hunter | Biotech Hunter